| Net Cash Provided by (Used in) Operating Activities |
144M |
USD |
+12696% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-95.3M |
USD |
-550% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
88.1M |
shares |
+7.1% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
47.5M |
USD |
|
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
79.6M |
USD |
+1.38% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
27.6M |
USD |
-0.11% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
6.2M |
USD |
-28.7% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
6.5M |
USD |
-25.3% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
14K |
USD |
|
Q4 2024 |
Q1 2025 |
| Additional Paid in Capital |
2.35B |
USD |
+3.78% |
Q3 2025 |
FY 2025 |
| Interest Expense |
116M |
USD |
-9.93% |
Q3 2025 |
FY 2025 |